Sequoia Financial Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61K Sell
21,951
-68,619
-76% -$19.2K ﹤0.01% 2162
2026
Q1
$29.8K Buy
90,570
+2,103
+2% +$3.31K ﹤0.01% 1901
2025
Q4
$274K Sell
88,467
-29,033
-25% -$82.8K ﹤0.01% 1609
2025
Q3
$309K Sell
117,500
-1,000
-0.8% -$2.2K ﹤0.01% 1382
2025
Q2
$146K Hold
118,500
﹤0.01% 1510
2025
Q1
$130K Hold
118,500
﹤0.01% 1308
2024
Q4
$107K Hold
118,500
﹤0.01% 1281
2024
Q3
$117K Buy
118,500
+25,000
+27% +$24.1K ﹤0.01% 1218
2024
Q2
$84.2K Buy
93,500
+20,000
+27% +$15K ﹤0.01% 1173
2024
Q1
$86.7K Buy
73,500
+5,000
+7% +$5.5K ﹤0.01% 1124
2023
Q4
$62.5K Buy
68,500
+10,000
+17% +$7.39K ﹤0.01% 1175
2023
Q3
$48.7K Hold
58,500
﹤0.01% 944
2023
Q2
$70.2K Hold
58,500
﹤0.01% 942
2023
Q1
$73.7K Buy
58,500
+30,000
+105% +$57.4K ﹤0.01% 819
2022
Q4
$61.8K Buy
28,500
+17,500
+159% +$144K ﹤0.01% 785
2022
Q3
$132K Buy
+11,000
New +$137K ﹤0.01% 504

Other funds holding GOSS

Sequoia Financial Advisors's GOSS Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Gossamer Bio (GOSS) stake by 76% in Q2 2026, selling an estimated $19.2K and leaving 21,951 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2162.

Sequoia Financial Advisors first reported a position in GOSS in Q3 2022 and has held it in 16 quarters since. The position peaked at $309K in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Sequoia Financial Advisors held 21,951 shares of Gossamer Bio worth $3.61K as of Q2 2026.
  • Sequoia Financial Advisors sold 68,619 Gossamer Bio shares in Q2 2026, an estimated $19.2K.
  • Gossamer Bio made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2162 holding.
  • Sequoia Financial Advisors first reported a position in Gossamer Bio in Q3 2022 and has held it in 16 quarters since.
  • Sequoia Financial Advisors's Gossamer Bio position peaked at $309K in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.